At-home OCT enables daily monitoring of patients with neovasular age-related macular degeneration (AMD) and other patients that need a lot of follow-ups. With host Carey Powers, Dr. Anat Loewenstein dives into at-home OCT innovation, application, and adoption. Dr. Loewenstein is Head of the Department of Ophthalmology and Vice Dean at Tel Aviv Medical Center. She’s also a fellowship-trained vitreoretinal surgeon and has been heavily involved in research related to early AMD detection. Why all the fuss about at-home OCT? An at-home monitoring solution will potentially lessen the number of appointments for patients who don’t need them. More-frequent monitoring could also help catch disease changes sooner so doctors can facilitate treatment asap. Listen to the podcast today to discover: How at-home OCT works and the role artificial intelligence (AI) plays in image analysis.The patient experience when using at-home OCT.How disease activity alerts are delivered from the at-home device to the physician.Once a physician receives an alert, steps to take to get the patient into the clinic right away.The status of products closest to FDA approval, such as Notal Home OCT from Notal Vision.Dr. Loewenstein’s thoughts on the global health implications of at-home OCT.[Listen Now] Resources Anat Loewenstein: linkedin.com/in/anat-loewenstein-b48a595 Carey Powers: ois.net/carey-powers